Cargando…

The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles

BACKGROUND: The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR) γ Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influence on lipid and lipoprotein profiles of patients. MATERIALS AND METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Rahimi, Zohreh, Chamaie-Nejad, Foroogh, Saeidi, Shohreh, Rahimi, Ziba, Ebrahimi, Ali, Shakiba, Ebrahim, Vaisi-Raygani, Asad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royan Institute 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936613/
https://www.ncbi.nlm.nih.gov/pubmed/29707932
http://dx.doi.org/10.22074/ijfs.2018.5270
_version_ 1783320497498357760
author Rahimi, Zohreh
Chamaie-Nejad, Foroogh
Saeidi, Shohreh
Rahimi, Ziba
Ebrahimi, Ali
Shakiba, Ebrahim
Vaisi-Raygani, Asad
author_facet Rahimi, Zohreh
Chamaie-Nejad, Foroogh
Saeidi, Shohreh
Rahimi, Ziba
Ebrahimi, Ali
Shakiba, Ebrahim
Vaisi-Raygani, Asad
author_sort Rahimi, Zohreh
collection PubMed
description BACKGROUND: The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR) γ Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influence on lipid and lipoprotein profiles of patients. MATERIALS AND METHODS: The present cross-sectional study consisted of 50 women with PCOS, who referred to the Kermanshah University of Medical Sciences Clinic between April and October 2015, and 233 unrelated age-matched healthy women from the same region (West Iran). The PPARγ Pro12Ala and PPARγ C161T polymorphisms were gen- otyped using the polymerase chain reaction-restriction fragment length polymorphism method. Fasting blood sugar (FBS), serum triglycerides (TG), cholesterol, low density lipoprotein- cholesterol (LDL-C), high density lipoprotein- cholesterol (HDL-C) and estradiol levels were measured. RESULTS: The serum level of estradiol was significantly lower in PCOS patients compared to healthy women. The PPARγ Pro12Ala (CG) genotype increased the risk of PCOS 2.96-fold. The frequency of the PPARγ T allele (at C161T) was 21% in patients and 17.2% in controls with no significant difference (P=0.52). In all studied individuals, the PPARγ CG geno- type was associated with significantly higher levels of TG. However, significantly lower levels of total cholesterol and LDL-C were observed in PPARγ TT individuals compared with those with the CC genotype. Within the PCOS group, the PPARγ CG genotype was significantly associated with lower levels of estradiol compared with the CC genotype. Also, the CG genotype was significantly associated with higher levels of TG when compared with the CC genotype. CONCLUSION: Our study shows that, unlike PPARγ C161T, PPARγ Pro12Ala is associated with the risk of PCOS. Also, we found that the lipid and lipoprotein profiles significantly vary based on PPARγ Pro12Ala and C161T genotypes.
format Online
Article
Text
id pubmed-5936613
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Royan Institute
record_format MEDLINE/PubMed
spelling pubmed-59366132018-07-01 The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles Rahimi, Zohreh Chamaie-Nejad, Foroogh Saeidi, Shohreh Rahimi, Ziba Ebrahimi, Ali Shakiba, Ebrahim Vaisi-Raygani, Asad Int J Fertil Steril Original Article BACKGROUND: The aim of present study was to clarify the role of the peroxisome proliferator-activated receptor (PPAR) γ Pro12Ala and C161T polymorphisms in the pathogenesis of polycystic ovary syndrome (PCOS) and their influence on lipid and lipoprotein profiles of patients. MATERIALS AND METHODS: The present cross-sectional study consisted of 50 women with PCOS, who referred to the Kermanshah University of Medical Sciences Clinic between April and October 2015, and 233 unrelated age-matched healthy women from the same region (West Iran). The PPARγ Pro12Ala and PPARγ C161T polymorphisms were gen- otyped using the polymerase chain reaction-restriction fragment length polymorphism method. Fasting blood sugar (FBS), serum triglycerides (TG), cholesterol, low density lipoprotein- cholesterol (LDL-C), high density lipoprotein- cholesterol (HDL-C) and estradiol levels were measured. RESULTS: The serum level of estradiol was significantly lower in PCOS patients compared to healthy women. The PPARγ Pro12Ala (CG) genotype increased the risk of PCOS 2.96-fold. The frequency of the PPARγ T allele (at C161T) was 21% in patients and 17.2% in controls with no significant difference (P=0.52). In all studied individuals, the PPARγ CG geno- type was associated with significantly higher levels of TG. However, significantly lower levels of total cholesterol and LDL-C were observed in PPARγ TT individuals compared with those with the CC genotype. Within the PCOS group, the PPARγ CG genotype was significantly associated with lower levels of estradiol compared with the CC genotype. Also, the CG genotype was significantly associated with higher levels of TG when compared with the CC genotype. CONCLUSION: Our study shows that, unlike PPARγ C161T, PPARγ Pro12Ala is associated with the risk of PCOS. Also, we found that the lipid and lipoprotein profiles significantly vary based on PPARγ Pro12Ala and C161T genotypes. Royan Institute 2018 2018-03-18 /pmc/articles/PMC5936613/ /pubmed/29707932 http://dx.doi.org/10.22074/ijfs.2018.5270 Text en Any use, distribution, reproduction or abstract of this publication in any medium, with the exception of commercial purposes, is permitted provided the original work is properly cited http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Rahimi, Zohreh
Chamaie-Nejad, Foroogh
Saeidi, Shohreh
Rahimi, Ziba
Ebrahimi, Ali
Shakiba, Ebrahim
Vaisi-Raygani, Asad
The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
title The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
title_full The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
title_fullStr The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
title_full_unstemmed The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
title_short The Association of PPARγ Pro12Ala and C161T Polymorphisms with Polycystic Ovary Syndrome and Their Influence on Lipid and Lipoprotein Profiles
title_sort association of pparγ pro12ala and c161t polymorphisms with polycystic ovary syndrome and their influence on lipid and lipoprotein profiles
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5936613/
https://www.ncbi.nlm.nih.gov/pubmed/29707932
http://dx.doi.org/10.22074/ijfs.2018.5270
work_keys_str_mv AT rahimizohreh theassociationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT chamaienejadforoogh theassociationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT saeidishohreh theassociationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT rahimiziba theassociationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT ebrahimiali theassociationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT shakibaebrahim theassociationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT vaisirayganiasad theassociationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT rahimizohreh associationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT chamaienejadforoogh associationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT saeidishohreh associationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT rahimiziba associationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT ebrahimiali associationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT shakibaebrahim associationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles
AT vaisirayganiasad associationofppargpro12alaandc161tpolymorphismswithpolycysticovarysyndromeandtheirinfluenceonlipidandlipoproteinprofiles